KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Archer-Daniels-Midland (ADM) Cash & Equivalents (2016 - 2025)

Archer-Daniels-Midland's Cash & Equivalents history spans 17 years, with the latest figure at $1.2 billion for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 57.53% year-over-year to $1.2 billion; the TTM value through Sep 2025 reached $1.2 billion, up 57.53%, while the annual FY2024 figure was $611.0 million, 55.34% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $1.2 billion at Archer-Daniels-Midland, up from $1.1 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.5 billion in Q3 2023 and bottomed at $611.0 million in Q4 2024.
  • The 5-year median for Cash & Equivalents is $943.0 million (2021), against an average of $1.0 billion.
  • The largest annual shift saw Cash & Equivalents plummeted 85.34% in 2021 before it skyrocketed 57.53% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $943.0 million in 2021, then rose by 9.97% to $1.0 billion in 2022, then skyrocketed by 31.92% to $1.4 billion in 2023, then tumbled by 55.34% to $611.0 million in 2024, then skyrocketed by 102.13% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ADM's Cash & Equivalents are $1.2 billion (Q3 2025), $1.1 billion (Q2 2025), and $864.0 million (Q1 2025).